Financials
- Market Capitalization 201.76 M
- Employee 108
- Founded 2015
- CEO N/A
- Website www.nkartatx.com
- Headquarter Delaware, United States
- FIGI BBG00JXHS9G7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.31
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3619 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 73.82 USD | -0.12% | -0.09% | +1.12% | +832.07% | 205.67 M USD | ||
| 3620 | CDXS Codexis, Inc. - Common Stock | 2.18 USD | -3.11% | -14.51% | -12.10% | -29.45% | 198.15 M USD | ||
| 3631 | IMUX Immunic, Inc. - Common Stock | 15.36 USD | +4.92% | +0.07% | +10.03% | +1707.06% | 209.23 M USD | ||
| 3639 | NERV Minerva Neurosciences, Inc - Common Stock | 4.27 USD | 0.00% | -12.14% | -7.38% | +142.61% | 198.93 M USD |